Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1982-10-15
1984-07-03
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 39018
Patent
active
044579152
ABSTRACT:
This invention relates to a method of preparation of a babesiosis vaccine which involves treating a suspension of Babesia infected erythrocytes. The erythrocytes are disintegrated, separated into soluble and insoluble fractions and subsequently fibrinogen and contaminated Babesia antigen is removed from the soluble fraction. The residual soluble fraction is then combined with an adjuvant to form the babesiosis vaccine. The invention also includes within its scope a vaccine derived from the abovementioned method and a method of administration of the vaccine to cattle.
REFERENCES:
patent: 3511908 (1970-05-01), Brock et al.
patent: 3849551 (1974-11-01), D'Antonio
patent: 3911097 (1975-10-01), Hanson
Wright et al., Australian Advances in Veterinary Science, 1979, pp. 72-73, "Babesia bovis Infections: New Concepts in Vaccination".
Goodger, B. V., (1971), Preparation and Preliminary Assessment of Purified Antigens in the passive . . . , Aust. Vet. J. 47: 251-256.
Goodger, B. V., (1973), Babesia argentina: Intraerythrocytic Location of Babesial Antigen Extracted . . . , Int. J. Parasit. 3: 387-391.
Goodger, B. V., (1976), Babesia argentina: Studies on the Nature of an Antigen Associated with Infection, Int. J. Parasit. 6: 213-216.
Mahoney, D. F. & Wright, I. G., (1976), Babesia argentina: Immunization of Cattle with a Killed Antigen . . . , Vet. Parasit. 2: 273, 282.
Mahoney, D. F., Wright, I. G. & Goodger, B. V., (1981), Bovine babesiosis: The Immunization of . . . , Vet. Immunol. and Immunopathol.
Ristic, M. & Sibinovic, S., (1964), Equine babesiosis: Diagnosis by a Precipitation in Gel and by . . . , Am. J. Vet. Res. 25: 1519-1526.
Sibinovic, S., Sibinovic, K. H., Ristic, M. & Cox, H. W., (1966), Physical and Serologic Properties . . . , J. Protozool. 13: 551-553.
Goodger et al., Int. J. Parasitol. 10 (1) (1980): 33-36.
Mahoney et al., Int. J. Parasitol. 9 (4): 297-306; (Aug. 1979).
Goodger et al., Z. Parasitenko, 53 (1) (1977): 47-52.
Mahoney et al., Exp. Parasitol. 32 (1) (1972): 71-85.
Mahoney et al., Australian Vet. J. 55 (1): 10-12 Jan. 1979.
Goodger et al., Austr. J. Exp. Bioc. Med. Sci. 54 (4): 381-390, Aug. 1976.
Goodger, Z. Parasitenko, 48 (1): 1-7 (1975).
Mahoney, Immunity to Animal Parasites, pp. 301-341 (1972).
Smith et al., Am. J. Vet. Res. 40(12): 1678-1682, Dec. 1979, Bovine Babesiosis: Vaccination Against Tick-Borne Challenge Exposure with Culture-Derived Babesia bovis Immunogens.
Gravely et al., Vet. Bull. 50(6) #3504 Jun. 1980 of Int. J. Parasitology (1979) 9(6): 591-598, Bovine Babesiosis: Partial Purification and Characterization of Blood Culture-Derived Babesia bovis.
James et al., Vet. Bull. 51(7) #4153 Jul. 1981 of Infection & Immunity (1981) 31(1): 358-361, Isolation and Partial Characterization of Culture-Derived Soluble Babesia bovis antigens.
Smith et al., Vet. Bull. 51(8) #4965 Aug. 1981 of Science (USA) 212(4492): 335-338, Bovine Babesiosis: Protection of Cattle with Culture-Derived Soluble Babesia bovis antigen.
Goodger Brian V.
Mahoney David F.
Wright Ian G.
LandOfFree
Babesiosis vaccine prepared from soluble parasitic antigen facto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Babesiosis vaccine prepared from soluble parasitic antigen facto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Babesiosis vaccine prepared from soluble parasitic antigen facto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1630112